SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies - Quaterly Results

29 Oct 2024 Evaluate
The revenue declined to Rs. 1670.20 millions for the quarter ended September 2024 as compared to Rs. 1701.90 millions during the corresponding quarter last year.Profit after tax for the quarter ended September 2024 reported a huge growth of 69.91% to Rs. 92.60  millions from Rs. 54.50 millions.The company reported a good operating profit of 209.80 millions compared to 160.60 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1670.20 1701.90 -1.86 2728.80 2688.20 1.51 5752.10 5376.60 6.98
Other Income 107.10 29.30 265.53 122.70 49.90 145.89 113.20 101.70 11.31
PBIDT 209.80 160.60 30.64 368.20 315.90 16.56 722.00 717.00 0.70
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 209.80 160.60 30.64 368.20 315.90 16.56 722.00 717.00 0.70
Depreciation 61.70 62.10 -0.64 119.30 135.30 -11.83 255.50 313.70 -18.55
PBT 148.10 98.50 50.36 248.90 180.60 37.82 466.50 403.30 15.67
TAX 55.50 44.00 26.14 111.80 82.70 35.19 161.50 113.70 42.04
Deferred Tax 18.30 7.20 154.17 49.20 12.00 310.00 39.30 113.70 -65.44
PAT 92.60 54.50 69.91 137.10 97.90 40.04 305.00 289.60 5.32
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 12.56 9.44 33.12 13.49 11.75 14.82 12.55 13.34 -5.88

Venus Remedies Share Price

1042.35 3.25 (0.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×